Monday, March 9, 2020
PT. Merck Sharp Dohme Pharma Tbk
Wisma BNI 46, Floor 27
Jend. Sudirman street Lot.1
- Approval of the Annual Report of the Board of Directors of the Company's Business Activities and Corporate Financial Administration in the financial year 2018.
- Ratification of the Company's Balance Sheet and Income statement the financial year 2018.
- Determination on the use of the Company's profit of the financial year 2018.
- Election of a Public Accountant Firm to audit the Company's Financial Report of the financial year 2019.
SCPI - PT. Organon Pharma Indonesia Tbk